Technetium (99mTc) nofetumomab merpentan

Last updated
Technetium (99m
Tc) nofetumomab merpentan
Technetium-99m nofetumomab merpentan skeletal.svg
Monoclonal antibody
Type Fab fragment
Source Mouse
Clinical data
Trade names Verluma
ATC code
  • none
Pharmacokinetic data
Elimination half-life 10.5 hours
Excretion renal (64%)
Identifiers
CAS Number
ChemSpider
  • none
UNII
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Technetium (99mTc) nofetumomab merpentan (trade name Verluma) is a mouse monoclonal antibody derivative used in the diagnosis of lung cancer, [1] gastrointestinal, breast, ovary, pancreas, kidney, cervix, and bladder carcinoma. [2] The antibody part, nofetumomab, is attached to the chelator merpentan, which links it to the radioisotope technetium-99m (99mTc). [3]

Contents

Nofetumomab

Nofetumomab is an antibody fragment that recognises the pancarcinoma glycoprotein antigen EpCAM. [4] and/or CD20/MS4A1 [5]

It is the Fab part of murine MAb NR-LU-10. [6]

Merpentan

The chelator part : merpentan is a phenthioate ligand, 2,3,5,6-tetrafluorophenyl-4,5-bis-5-[1-ethoxyethyl]-thioacetoamidopentanoate. [6]

Phenthioate

Phenthioate is an insecticide (Cidial) = O,o-dimethyl-S-(carbethoxy-phenylmethyl)dithiophosphate [7]

References

  1. ↑ Straka MR, Joyce JM, Myers DT (January 2000). "Tc-99m nofetumomab merpentan complements an equivocal bone scan for detecting skeletal metastatic disease from lung cancer". Clinical Nuclear Medicine. 25 (1): 54–5. doi:10.1097/00003072-200001000-00013. PMID   10634533.
  2. ↑ Breitz HB, Tyler A, Bjorn MJ, Lesley T, Weiden PL (September 1997). "Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy". Clinical Nuclear Medicine. 22 (9): 615–20. doi:10.1097/00003072-199709000-00007. PMID   9298295.
  3. ↑ "International Nonproprietary Names (INN) for pharmaceutical substances" (PDF). Geneva: World Health Organization. 2002. Archived from the original (PDF) on July 3, 2011.
  4. ↑ Tsurushita N, Vasquez M (January 2004). "Humanization of monoclonal antibodies". In Reth M, Radbruch A, Alt F, Honjo T, Neuberger M (eds.). Molecular Biology of B Cells. Academic Press. pp. 533–545. ISBN   978-0-08-047950-7.
  5. ↑ "Anti-MS4A1 Therapeutic Antibody (Technetium (99MTC) Nofetumomab Merpentan)". Creative BioLabs.
  6. 1 2 Mudd E (27 February 2015). "Monoclonal Antibody Radionuclide Test Kits". Pharmacological Sciences.
  7. ↑ US 3934010,Drabek J, Varsanyi D,"Insecticidal composition and method utilizing phosphoric acid phenylsulphonamide esters",issued 20 January 1976, assigned to Ciba Geigy Corporation


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.